Integration of PARP-inhibitors in ovarian cancer therapy

• Main Authors: Antonella Pietragalla (Author), Francesca Ciccarone (Author), Camilla Nero (Author), Giovanni Scambia (Author), Domenica Lorusso (Author), Gennaro Daniele (Author)
• Format: Book
• Published: Open Exploration Publishing Inc., 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Poly-ADP-ribose polymerase inhibitors (PARP-I) represent one of the most attractive and promising class of biological agents studied both in relapsed ovarian cancer (OC) and in the advanced setting. The availability of this new class of drugs has changed the clinical management of OC ensuring an unp...